March 11, 2020 - EXHIBIT 21.1 - 10-K: Annual report pursuant to Section 13 and 15(d) | Avalo Therapeutics, Inc. (AVTX)

Form: 10-K

Annual report pursuant to Section 13 and 15(d)

March 11, 2020

Documents

Exhibit 21.1


List of Subsidiaries of Cerecor Inc.

Entity Name
Jurisdiction
Ichorion Therapeutics, LLC
Delaware
Aevi Genomic Medicine, LLC
Delaware
Medgenics Medical (Israel) Ltd.
State of Israel
neuroFix, LLC
Delaware
Aevi Genomic Medicine Europe BVBA/SPRL
Belgium
TRx Pharmaceuticals, LLC
North Carolina
Zylera Pharmaceuticals, LLC
North Carolina
Zylera Pharma Corp.
North Carolina